Navigation Links
Combination therapy boosts effectiveness of telomere-directed cancer cell death

ition is combined with inhibition of an enzyme called tankyrase 1 that is involved in making telomeres accessible to telomerase. The researchers found that both tankyrase 1 activity and telomere shortening decrease the effects of telomerase inhibitors. Importantly, tankyrase inhibition enhanced telomere shortening upon treatment with a telomerase inhibitor and accelerated cancer cell death. "This study provides insight into strategies for telomere-based molecular cancer therapeutics. We expect that inhibition of tankyrase 1 will compensate for incomplete inhibition of telomerase. Consequently, this strategy would shorten the time period of drug treatment that is required for the onset of telomere crisis and reduce the potential risk of acquired drug resistance, " writes Dr. Seimiya. Hiroyuki Seimiya, Yukiko Muramatsu, Tomokazu Ohishi, and Takashi Tsuruo: "Tankyrase 1 as a target for telomere-directed molecular cancer therapeutics".
'"/>

Source:Eurekalert


Page: 1 2

Related biology news :

1. Combination therapy leads to partial recovery from spinal cord injury in rats
2. Combination therapy improves AIDS-related lymphoma outcome
3. Combination therapy with a monocloncal antibody and a vaccine leads to tumor rejection
4. Combination therapy shows promising results in patients with advanced lung cancer
5. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
6. Columbia research lifts major hurdle to gene therapy for cancer
7. Gene therapy converts dead bone graft to new, living tissue
8. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
9. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
10. Muscle-targeted gene therapy reverses rare muscular dystrophy in mice
11. New therapy for HIV/AIDS eliminates needles and excessive toxicity
Post Your Comments:
(Date:4/20/2015)... , April 20, 2015 Huntington Memorial ... Valley to implant a new miniaturized, wireless monitoring sensor ... is the first and only FDA-approved heart failure monitoring ... admissions when used by physicians to manage heart failure. ... that is implanted in the pulmonary artery (PA) during ...
(Date:4/14/2015)... OXFORD, Conn. , April 14, 2015 ... "Company"), a biometric authentication company focused on the growing ... has been nominated for the 2015 New York Design ... The Design100, New York City Design Awards are ... are based on over 2,500 ratings from the marketplace, ...
(Date:4/9/2015)... Calif. , April 9, 2015 Synaptics ... interface solutions, announced today that it will report financial ... Thursday, April 23, 2015, after the close of market. ... analysts and investors at 2:00 p.m. PT (5:00 p.m. ... To participate on the live call, analysts ...
Breaking Biology News(10 mins):Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3Synaptics to Report Third Quarter Results on April 23 2
... the Bronx Zoo-based Wildlife Conservation Society (WCS) warn that ... Asia and beyond must focus on better management practices ... working with Mongolian agencies on the ground in Mongolia's ... recently contracted the virus. , "We're working with our ...
... modest suppression of growth hormone and related compounds beginning ... of several types of cancer, researchers from Wake Forest ... at ENDO 2005, the annual meeting of the Endocrine ... and insulin-like growth factor (IGF-1) also may decrease cancer ...
... researchers have discovered an inherited structural mechanism that ... some patients. The mechanism decreases a protein and ... drugs differently. Thiopurine therapies are used to treat ... transplants. The Mayo researchers say their finding advances ...
Cached Biology News:WCS says avian flu prevention should focus on farms, markets 2Suppressing growth hormone in early adulthood may prevent cancer 2Genomics researchers discover protein deficit that causes drug toxicity 2
(Date:4/23/2015)... /CNW/ - A new and innovative service has won ... North America,s largest packaging trade association. ... the "Sustainability, service" category of the PAC Global ... is a service that scores clients, packaging against ... This benchmarking process shows clients how their packaging ...
(Date:4/23/2015)... 2015  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) ... quarter 2015 results before the Nasdaq market opens on ... conference call and webcast to discuss its financial results ... 2015 at 8:00 a.m. Eastern Time (5:00 a.m. Pacific ... call by dialing 866-952-1906 (US) or 785-424-1825 (International) using ...
(Date:4/23/2015)... April 23, 2015  Cryoport, Inc. (OTCBB: CYRX) ... solutions for the life sciences industry, today announced ... logistics solutions within the animal husbandry market by ... to support the shipment of equine semen for ... horse Stallions. Animal husbandry is a ...
(Date:4/23/2015)... Glemser Technologies is ... Enterprise Content Division (ECD) Certified Solution Partner to ... for Life Sciences Solution Suite . The accreditation ... to provide life sciences companies of all sizes ... EMC Documentum Solution Suite offers four modules: Quality ...
Breaking Biology Technology:Neurocrine Biosciences Announces Conference Call and Webcast to Report First Quarter 2015 Results 2Cryoport to Support the Equine Animal Husbandry Market Through Agreement with Yancey Farms 2Cryoport to Support the Equine Animal Husbandry Market Through Agreement with Yancey Farms 3Glemser Earns Accreditation for Life Sciences Solution Suite 2
... 25 NanoBio(R) Corporation, a,biopharmaceutical company developing novel ... serious infections, today announced,the addition of four new ... Ma, PharmD, Ph.D.; Susan Ciotti, Ph.D.; Robert L. ... in developing and commercializing,its novel topical anti-infectives and ...
... Cell biologist receives $500,000 ,genius award, with ,no ... Roth, Ph.D., a cell biologist at,Fred Hutchinson Cancer ... MacArthur Fellowships, a "genius" award given annually by ... will receive $500,000 over,five years of "no-strings-attached" support. ...
... ST. LOUIS and REHOVOT, Israel, Sept. 25 ,Monsanto ... (TASE: EVGN) today announced,a collaboration to improve nitrogen ... the agreement, Monsanto gains exclusive rights to,a number ... maintain yield,with lower applications of nitrogen. Monsanto will ...
Cached Biology Technology:NanoBio Expands Drug Development Team for Its Anti-Infective Products 2NanoBio Expands Drug Development Team for Its Anti-Infective Products 3Basic Scientist Mark Roth Wins MacArthur Fellowship 2Basic Scientist Mark Roth Wins MacArthur Fellowship 3Monsanto and Evogene Collaborate on Nitrogen Use Efficiency Research 2Monsanto and Evogene Collaborate on Nitrogen Use Efficiency Research 3